Functional Brands Announces Adjournment of Special Meeting of Stockholders
Scheduled to Reconvene on June 1, 2026Lake Oswego, Oregon--(Newsfile Corp. - May 27, 2026) - Functional Brands Inc. (NASDAQ: MEHA),...
Day: May 27, 2026
Wellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5M
New oversubscribed $21 million convertible debt instrument ("New Debt") refinances all outstanding convertible debt, provides $6.5 million in new capital...
Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment
Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patientsCollaboration supports the...
Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment
Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patientsCollaboration supports the...
NordicNeuroLab and GE HealthCare Enter Strategic Software License and Distribution Agreement to Advance Neuroimaging Worldwide
A collaboration for advancing neuroimaging MILWAUKEE, WI / ACCESS Newswire / May 27, 2026 / NordicNeuroLab announced the signing of...
Jaguar Health Compliant with Nasdaq Bid Price Rule
JAGX's securities continue to be listed and traded on Nasdaq SAN FRANCISCO, CA / ACCESS Newswire / May 27, 2026...
Aetna Better Health of Missouri Collaborates With Local Organizations To Address Food Insecurity and Enhance Safety and Wellness Supports
$175,000 investment to support communities in southern Missouri, Kansas City and St. Louis areasOriginally published on CVS Health Company Newsroom...
Aspire Biopharma’s BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members
ESTERO, FL / ACCESS Newswire / May 27, 2026 / Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire" or the "Company") wholly...
Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing
50/50 Strategic Collaboration Will Develop Up to Three Radiopharmaceutical ProgramsInnovation and Investment Continue to Accelerate Across Radiopharmaceutical Oncology SEATTLE, WA...
MIRA Pharmaceuticals Secures Worldwide Rights for Ketamir-2, Expanding Global IP Portfolio Across 10 Major Markets Ahead of Phase 2a in CIPN
Expanded Global Intellectual Property Portfolio Enhances Strategic Flexibility and Long-Term Value Potential for Ketamir-2 MIAMI, FL / ACCESS Newswire /...
Southern California Reproductive Center Joins Nucleus IVF+ Network as Patient Demand Accelerates
The move brings Genetic Optimization to one of the most sought-after fertility clinics in the U.S., following Nucleus’ rapid global...
AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates
AsymBio’s Conjugation Toolbox supports customized process development across both random and site-specific conjugation technologies.For IND-enabling programs, conjugation process development timelines...
JenaValve Appoints Edward Sarnowski as Chief Technology Officer
IRVINE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve...
Privia Health Enters New Jersey
Represents 25th State in National Primary Care-Centric Care Delivery NetworkARLINGTON, Va., May 27, 2026 (GLOBE NEWSWIRE) -- Privia Health Group,...
AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration
Previously published Biosafety Level 4 pre-clinical study showed 100% survival with early treatment following infection in a mouse model following...
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
Broad-spectrum antiviral agent with potential utility against Hantavirus, Ebola and Lassa Utilizing a novel dual-strike mechanism, the proprietary combination agent...
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
ROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug...
20/20 Biolabs’ Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
Comprehensive Cancer Screening Initiative Expected to Generate Approximately $500,000 in Testing Revenues to 20/20 from the First Cohort GAITHERSBURG, Md.,...
Altimmune to Participate in Upcoming Investor Conferences
GAITHERSBURG, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to...
EOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer Patients
MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) (“EOM”, the “Company”) an innovative clinical-stage...